Navigation Links
Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
Date:12/9/2007

sible damage. Thalidomide may also potentially aggravate existing neuropathy and should therefore not be used in patients with clinical signs or symptoms of peripheral neuropathy unless the clinical benefits outweigh the risks. Symptoms may occur some time after thalidomide treatment has been stopped and may resolve slowly or not at all. Thalidomide frequently causes drowsiness, somnolence and sedation. Patients should be instructed to avoid situations where drowsiness may be a problem.

About Multiple Myeloma

Multiple myeloma (also known as myeloma or plasma cell myeloma) is a cancer of the blood in which malignant plasma cells are overproduced in the bone marrow. Plasma cells are white blood cells that help produce antibodies called immunoglobulins that fight infection and disease. However, most patients with multiple myeloma have cells that produce a form of immunoglobulin called paraprotein (or M protein) that does not benefit the body. In addition, the malignant plasma cells replace normal plasma cells and other white blood cells important to the immune system. Multiple myeloma cells can also attach to other tissues of the body, such as bone, and produce tumors. The cause of the disease is unknown.

About Pharmion

Pharmion is a leading global oncology company uniquely focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements, including summary statements relating to the interim or pr
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Thalidomide Improves Outcomes for Older Myeloma Patients
2. Corals added to IUCN Red List of Threatened Species for first time
3. Halozyme Therapeutics Added to Nasdaq Biotech Index
4. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
5. Standard Management Announces OTCBB Listing
6. Gastroenterology sets standards for CT colonography
7. Public Health and Need for Consistent Standards Preclude Exception for Breastfeeding Mother in National Medical Licensing Test
8. New Drug No Substitute for Standard Blood-Clot Therapy
9. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
10. New guidelines set to improve standard of cows milk allergy care
11. Green Seal Ramps Up Environmental Standard for Household Cleaners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Pennsylvania (PRWEB) , ... July ... ... largest e-commerce janitorial supply company , announced today that it has ... Products. The acquisition will make CleanItSupply.com the largest distributor of Rubbermaid Commercial ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies ... pain treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation ... on the conservative treatment of back, hip, knee and shoulder pain as well ...
(Date:7/2/2015)... ... July 02, 2015 , ... Five ... Preparedness (CDP) in Anniston for specialized disaster training. The team – composed of ... the Southern California Hospital Association who attended the training, which is dedicated to ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/2/2015)... AR (PRWEB) , ... July 02, 2015 , ... Throughout ... families through their annual “Dog Tag” campaign. On Tuesday, July 7, Casey’s General ... Warriors® for nearly $800,000. Hope For The Warriors® is a national nonprofit dedicated to ...
Breaking Medicine News(10 mins):Health News:CleanItSupply.com Acquires eRubbermaid.com 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3
... of effectiveness over time , , MONDAY, May 12 (HealthDay News) ... legs syndrome do provide relief, but they are burdened by ... many sufferers to stop taking them, a new analysis finds. ... can,t fully explain is that they have more robust effects ...
... baby boomers say,they are financially unprepared for a ... Harris Interactive on behalf of America,s Health,Insurance Plans ... and,many would have to tap into their retirement ... ), "Baby boomers have too much ...
... assessments worldwide verify safety and quality of technically ... advanced zirconium oxide material., ... provider of,ceramic solutions for the medical device industry, has submitted ... (FDA) for,its new technical ceramic dental component, ZirDent(TM) CAD/CAM Blocks.,ZirDent(TM) ...
... CHENGDU, China, May 12 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Co., ... of modernized traditional Chinese medicine ("TCM") based in,Chengdu, ... at Roth Third,Annual China Discovery Tour on Tuesday, ... Conference will be held at the Regent Hotel ...
... trial in bladder cancer exceeds 2/3rds enrolment level ... pre-clinical work in peritoneal cancers -, BELLEVILLE, ... (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, is ... non-clinical development of its proprietary platform technology:,Mycobacterial Cell ...
... Re-implantation of devices at shorter distances improved motor scores, ... A few millimeters can make a huge difference for ... brain, a new study finds. , Implanting electrodes ... brain potentially related to impulsivity, has helped people with ...
Cached Medicine News:Health News:Drugs for Restless Legs Syndrome Have Downsides 2Health News:Drugs for Restless Legs Syndrome Have Downsides 3Health News:Most Baby Boomers are Financially Unprepared for a Potential Disability 2Health News:C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks 2Health News:Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time 2Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 2Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 3Health News:Bioniche Updates re: Mycobacterial Cell Wall Technology Platform 4Health News:Electrode Placement Key to Brain Stimulation for Parkinson's Patients 2
(Date:7/2/2015)... , June 25, 2015 ... of the "Veterinary / Animal Vaccines Market by ... report to their offering. The global ... by 2020 from $5,507.3 Million in 2015, at a ... Major factors fueling market growth are growing prevalence of ...
(Date:7/2/2015)... Agreement reinforces ...   ViiV Healthcare and Desano Pharmaceuticals (Desano) ... China of dolutegravir. The agreement will ... (API), and will allow ViiV Healthcare to offer a competitive ... name Tivicay®) for China and a ...
(Date:7/1/2015)... Colo. , July 1, 2015   ... in implantable hearing solutions, announced today the US ... Cochlear™ Nucleus® Profile™ Implant with Slim Straight Electrode ... and developed in close collaboration with the world,s ... cochlear implant platform designed to provide the most ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 3
... Inc. (Nasdaq: MYL ) today announced that its ... Food and Drug Administration (FDA) for its Abbreviated New Drug ... and 500 mg Single-use Vials. This product is the generic ... a chemoprotective agent. Dexrazoxane for Injection, when indicated ...
... Nov. 28, 2011 Gaylord Sleep Medicine now offers ... Glastonbury, Guilford, North Haven and Trumbull locations. ... Sleep Apnea Management program has expanded to offer PAP ... needs. Originally designed to improve PAP compliance, the program ...
Cached Medicine Technology:Gaylord Sleep Medicine Expands Sleep Apnea Management Program 2
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Used for complex diagnostic and interventional procedures....
The Emerald Guidewire is intended for percutaneous introduction of catheters....
... Medical offers a complete line ... with percutaneous catheter introducers to ... catheters. Our diagnostic guidewires are ... incorporate a proprietary surface finish ...
Medicine Products: